Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06543147

Completed

Effect of Education on Breast Cancer Fear and Health Beliefs

Health Education | Women's Health
NCT03885648

Active, not recruiting

Breast Cancer and Its Relationship With the Microbiota (MICROMA)

Breast Cancer
NCT06076616

Completed

Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study (BREHAB)

Breast Cancer | Surgery | Rehabilitation | Lifestyle | Prehabilitation
NCT00036868

Completed

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT04995575

Terminated

Dissecting the Pathways of Therapy Resistance in Early Breast Cancer (MINDACTRelapse)

Breast Cancer
NCT05775822

Completed

Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer (RadioTherapy)

Breast Cancer
NCT06166173

Active, not recruiting

Using Color Doppler US Artifact to Identify Tumor Markers

Breast Cancer | Doppler Ultrasound | Interventional Radiology
NCT00258375

Completed

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer
NCT01439282

Completed

Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer

Breast Cancer | Estrogen Receptor Positive Tumor
NCT01269346

Completed

Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer

Breast Cancer
NCT00002826

Completed

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

Breast Cancer
NCT05232084

Completed

Different Volumes of Erector Spinae Plane Block for Breast Surgery

Breast Cancer | Breast Neoplasms | Breast Diseases
NCT00004935

Terminated

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Breast Cancer
NCT01875367

Completed

Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer (ChangHER-SC)

Breast Cancer
NCT01377363

Completed

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

Breast Cancer
NCT01022138

Terminated

Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer

Breast Cancer
NCT05510037

Completed

Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions

Breast Cancer
NCT04444882

Completed

Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Care (COTUKI)

Breast Neoplasm
NCT02684032

Completed

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Breast Cancer
NCT03874325

Terminated

Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer

Breast Cancer | Hormone Receptor Positive Tumor
NCT05041751

Withdrawn

Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome

Breast Carcinoma
NCT03628066

Completed

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Breast Cancer
NCT05160324

Active, not recruiting

T1-T2 Breast Cancer: Comparison Between Removal and Preservation of Axillary Lymph Nodes (SINODAR ONE) (SINODAR ONE)

Breast Cancer
NCT00703326

Completed

Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer

Breast Cancer
NCT00816582

Terminated

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

Breast Cancer
NCT03511079

Withdrawn

Music as a Perioperative Therapy in Breast Cancer Patients

Breast Cancer
NCT01077154

Terminated

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Breast Cancer
NCT01847001

Completed

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Breast Cancer | Locally Advanced Malignant Neoplasm
NCT01157767

Completed

Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation

Breast Cancer
NCT02551263

Completed

Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer (E-SPEC)

Breast Cancer
NCT02732119

Completed

Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. (TRINITI-1)

Breast Cancer
NCT02878057

Completed

Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)

Breast Cancer
NCT01777958

Completed

HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin Therapy

Breast Cancer
NCT03819010

Completed

Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 - (DxCARTES)

Breast Cancer
NCT03835897

Unknown

Breast Cancer Screening With Diffusion-weighted MRI in Women at High Risk for Breast Cancer

Breast Cancer
NCT00138125

Terminated

Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

Breast Cancer
NCT00810797

Completed

Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer

Breast Cancer
NCT00033514

Completed

Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression

Breast Cancer
NCT04569955

Unknown

Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt

Breast Cancer | Clinical Trials
NCT03030677

Completed

Establishing Technique for PECS2 Catheter Insertion (ETCI)

Breastcancer | Phyllodes Breast Tumor
NCT00006682

Completed

Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT01034215

Completed

Multi-Media Imagery Program for Breast Cancer Patients (Phase II)

Breast Cancer
NCT00445445

Completed

Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women

Breast Cancer
NCT00079157

Completed

Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer

Breast Cancer
NCT01763931

Completed

DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer

Breast Cancer
NCT03498157

Completed

IMpact of PRehabilitation in Oncology Via Exercise - Breast Cancer (IMPROVE-B)

Breast Cancer | Physical Activity | Surgery | Prehabilitation
NCT00341159

Completed

Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study

Breast Cancer
NCT00003219

Completed

Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer

Breast Cancer
NCT04194684

Unknown

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Breast Cancer
NCT01840488

Completed

BN83495 Phase I in Post-menopausal Women

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations